PT72279B - Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof - Google Patents

Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof

Info

Publication number
PT72279B
PT72279B PT72279A PT7227980A PT72279B PT 72279 B PT72279 B PT 72279B PT 72279 A PT72279 A PT 72279A PT 7227980 A PT7227980 A PT 7227980A PT 72279 B PT72279 B PT 72279B
Authority
PT
Portugal
Prior art keywords
azidomethyl
benzodiazepines
dihydro
phenyl
salts
Prior art date
Application number
PT72279A
Other languages
English (en)
Other versions
PT72279A (en
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of PT72279A publication Critical patent/PT72279A/pt
Publication of PT72279B publication Critical patent/PT72279B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT72279A 1979-12-24 1980-12-23 Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof PT72279B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792952279 DE2952279A1 (de) 1979-12-24 1979-12-24 Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
PT72279A PT72279A (en) 1981-01-01
PT72279B true PT72279B (en) 1981-11-06

Family

ID=6089628

Family Applications (2)

Application Number Title Priority Date Filing Date
PT72278A PT72278B (en) 1979-12-24 1980-12-23 Process for the preparation of 2-acylaminomethyl-1,4-benzodiazepines and salts thereof
PT72279A PT72279B (en) 1979-12-24 1980-12-23 Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT72278A PT72278B (en) 1979-12-24 1980-12-23 Process for the preparation of 2-acylaminomethyl-1,4-benzodiazepines and salts thereof

Country Status (21)

Country Link
US (2) US4325957A (pt)
EP (1) EP0031080B1 (pt)
JP (1) JPS5699477A (pt)
AU (1) AU542701B2 (pt)
CA (1) CA1169425A (pt)
DD (2) DD155988A5 (pt)
DE (3) DE2952279A1 (pt)
DK (1) DK548080A (pt)
ES (2) ES8201143A1 (pt)
FI (1) FI68050C (pt)
GR (1) GR73080B (pt)
HU (1) HU185398B (pt)
IE (1) IE50580B1 (pt)
IL (1) IL61692A (pt)
NO (1) NO154883C (pt)
NZ (1) NZ195872A (pt)
PH (1) PH17189A (pt)
PT (2) PT72278B (pt)
SU (1) SU1253430A3 (pt)
YU (1) YU324780A (pt)
ZA (1) ZA807704B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
JPH01314666A (ja) * 1988-06-15 1989-12-19 Kayaba Ind Co Ltd パワーステアリング装置の操舵力制御装置
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
JPH0546660U (ja) * 1991-12-03 1993-06-22 カヤバ工業株式会社 パワーステアリング装置
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
DE60028387T2 (de) * 1999-08-27 2007-05-24 The Procter & Gamble Company, Cincinnati Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
CN1382205A (zh) * 1999-08-27 2002-11-27 宝洁公司 快速作用的制剂组分、使用该制剂组分的组合物和洗衣方法
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
CN113149914A (zh) * 2021-01-15 2021-07-23 福安药业集团重庆礼邦药物开发有限公司 一种咪达唑仑中间体脱氟杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681340A (en) * 1968-02-12 1972-08-01 Herman Robert Rodriguez 1,3-benzodiazepines
US3738999A (en) * 1970-05-28 1973-06-12 Squibb & Sons Inc 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
DE2353187A1 (de) * 1973-05-02 1974-11-14 Kali Chemie Ag Neue benzodiazepinderivate
US3925358A (en) * 1973-07-27 1975-12-09 Hoffmann La Roche 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US3947475A (en) * 1975-04-28 1976-03-30 Stauffer Chemical Company 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4087421A (en) * 1976-04-19 1978-05-02 American Cyanamid Company Substituted benzodiazepines and method of use

Also Published As

Publication number Publication date
CA1169425A (en) 1984-06-19
HU185398B (en) 1985-01-28
YU324780A (en) 1983-12-31
ES498072A0 (es) 1981-12-01
IL61692A (en) 1984-08-31
JPS5699477A (en) 1981-08-10
PH17189A (en) 1984-06-14
EP0031080A1 (de) 1981-07-01
DE2952279A1 (de) 1981-06-25
PT72278A (en) 1981-01-01
FI68050C (fi) 1985-07-10
NO154883B (no) 1986-09-29
DE3064983D1 (en) 1983-10-27
ES8201142A1 (es) 1981-12-01
DD200274A5 (de) 1983-04-06
DK548080A (da) 1981-07-23
IL61692A0 (en) 1981-01-30
EP0031080B1 (de) 1983-09-21
SU1253430A3 (ru) 1986-08-23
AU6566480A (en) 1981-07-02
AU542701B2 (en) 1985-03-07
ZA807704B (en) 1981-11-25
ES498071A0 (es) 1981-12-01
ES8201143A1 (es) 1981-12-01
IE802531L (en) 1981-06-24
DE3070798D1 (en) 1985-07-25
FI803988L (fi) 1981-06-25
IE50580B1 (en) 1986-05-14
FI68050B (fi) 1985-03-29
DD155988A5 (de) 1982-07-21
NZ195872A (en) 1983-06-17
JPS6332072B2 (pt) 1988-06-28
PT72278B (en) 1981-11-06
US4382030A (en) 1983-05-03
NO154883C (no) 1987-01-07
PT72279A (en) 1981-01-01
NO803935L (no) 1981-06-25
GR73080B (pt) 1984-01-31
US4325957A (en) 1982-04-20

Similar Documents

Publication Publication Date Title
PT72279A (en) Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof
AR244222A1 (es) Procedimiento para la preparacion de nuevos derivados de arilfenileter y sus sales
DE3060327D1 (en) Process for the preparation of organopolysiloxanes
DE3061812D1 (en) Process for the preparation of alkoxyalkanoic acids, and alkoxyalkanoic acids so prepared
GB2058063B (en) Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers
ZA804178B (en) Process for the preparation of 2,6-dialkylcyclohexylamines
PT71377A (en) Improved process for the preparation of viscose and process for the sminning of the viscose thus obtained
PT70537A (en) Process for the preparation of 2',6'-dialkyl-n-alkoxymethyl-2-chloro-acetanilides
PT71031B (en) Process for the preparation of benzodiazepine derivatives
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
DE3062050D1 (en) Gelatins, process for their preparation and their use
DE3365690D1 (en) Process for the preparation of 3,4,9,10-tetrathioperylene and 3,4,9,10-tetraselenoperylene
EP0021431A3 (en) Quaternary alkylamino-di-alkylcarbonic acid-di-esters, process for their preparation and their use
DE3063695D1 (en) Process for the preparation of substituted anilines, and substituted anilines
DE3061773D1 (en) Process for the preparation of trifluoromethyl naphthalenes
ZA803879B (en) Heterocyclic compounds, processes for their preparation and their use
PT72237A (en) Process for the preparation of new pyrrolbenzotriazepines having pharmaceutical effect
DE3062551D1 (en) Cationic compounds of the naphthalimide series, process for their preparation and their use
DE3371509D1 (en) Clavulone derivatives, process for preparing the same, and use of said compounds
YU100180A (en) New benzo-as-triazine derivatives and process for preparation thereof
DE3369132D1 (en) Process for the preparation of isomelamines, and their use
DE3067531D1 (en) Process for the preparation of 1,4-benzodiazepines
DE3060499D1 (en) Process for the preparation of pyridine-4-aldehyde-phenyl hydrazones
DE3062357D1 (en) Decahydroquinolinol derivatives, process for their preparation and their therapeutical use
PT71606A (en) Process for the preparation of benzodiazepine derivatives